HIRSCHMAN ORIN 13D and 13G filings for Cellectar Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-07-10 4:15 pm Sale |
2020-06-30 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 103,423 4.310% |
-53,097 (-33.92%) |
Filing |
| 2020-06-10 06:32 am Purchase |
2020-06-03 | 13G | Cellectar Biosciences, Inc. CLRB |
HIRSCHMAN ORIN | 156,520 6.520% |
156,520 (New Position) |
Filing |